TMPRSS2 and viral infectious disease: In response to the recent COVID-19 pandemic, the search for therapeutic targets to combat the severity and complications of infection caused by SARS-CoV-2 has led to the identification of SERPINE1 as a natural inhibitor of the TMPRSS2 protease that enhances the viral infection process.